Impact of reinfection with SARS-CoV-2 Omicron variants in previously infected hamsters
The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an in vivo, hamster infection model to assess the potenti...
Saved in:
Published in | bioRxiv |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Paper |
Language | English |
Published |
Cold Spring Harbor
Cold Spring Harbor Laboratory Press
01.09.2022
Cold Spring Harbor Laboratory |
Edition | 1.2 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an in vivo, hamster infection model to assess the potential for individuals previously infected with SARS-CoV-2 to be reinfected with Omicron variant and we also investigated the pathology associated with such infections. Initially, Syrian hamsters were inoculated with a lineage A, B.1.1.7, B.1.351, B.1.617.2 or a subvariant of Omicron, BA.1 strain and then reinfected with the BA.1 strain 5 weeks later. Subsequently, the impact of reinfection with Omicron subvariants (BA.1 and BA.2) in individuals previously infected with the BA.1 strain was examined. Although viral infection and replication were suppressed in both the upper and lower airways, following reinfection, virus-associated RNA was detected in the airways of most hamsters. Viral replication was more strongly suppressed in the lower respiratory tract than in the upper respiratory tract. Consistent amino acid substitutions were observed in the upper respiratory tract of infected hamsters after primary infection with variant BA.1, whereas diverse mutations appeared in hamsters reinfected with the same variant. Histopathology showed no acute pneumonia or disease enhancement in any of the reinfection groups and, in addition, the expression of inflammatory cytokines and chemokines in the airways of reinfected animals was only mildly elevated. These findings are important for understanding the risk of reinfection with new variants of SARS-CoV-2. Competing Interest Statement The authors have declared no competing interest. Footnotes * Add the Supplemental Materials |
---|---|
AbstractList | The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an in vivo, hamster infection model to assess the potential for individuals previously infected with SARS-CoV-2 to be reinfected with Omicron variant and we also investigated the pathology associated with such infections. Initially, Syrian hamsters were inoculated with a lineage A, B.1.1.7, B.1.351, B.1.617.2 or a subvariant of Omicron, BA.1 strain and then reinfected with the BA.1 strain 5 weeks later. Subsequently, the impact of reinfection with Omicron subvariants (BA.1 and BA.2) in individuals previously infected with the BA.1 strain was examined. Although viral infection and replication were suppressed in both the upper and lower airways, following reinfection, virus-associated RNA was detected in the airways of most hamsters. Viral replication was more strongly suppressed in the lower respiratory tract than in the upper respiratory tract. Consistent amino acid substitutions were observed in the upper respiratory tract of infected hamsters after primary infection with variant BA.1, whereas diverse mutations appeared in hamsters reinfected with the same variant. Histopathology showed no acute pneumonia or disease enhancement in any of the reinfection groups and, in addition, the expression of inflammatory cytokines and chemokines in the airways of reinfected animals was only mildly elevated. These findings are important for understanding the risk of reinfection with new variants of SARS-CoV-2. Competing Interest Statement The authors have declared no competing interest. Footnotes * Add the Supplemental Materials The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an in vivo, hamster infection model to assess the potential for individuals previously infected with SARS-CoV-2 to be reinfected with Omicron variant and we also investigated the pathology associated with such infections. Initially, Syrian hamsters were inoculated with a lineage A, B.1.1.7, B.1.351, B.1.617.2 or a subvariant of Omicron, BA.1 strain and then reinfected with the BA.1 strain 5 weeks later. Subsequently, the impact of reinfection with Omicron subvariants (BA.1 and BA.2) in individuals previously infected with the BA.1 strain was examined. Although viral infection and replication were suppressed in both the upper and lower airways, following reinfection, virus-associated RNA was detected in the airways of most hamsters. Viral replication was more strongly suppressed in the lower respiratory tract than in the upper respiratory tract. Consistent amino acid substitutions were observed in the upper respiratory tract of infected hamsters after primary infection with variant BA.1, whereas diverse mutations appeared in hamsters reinfected with the same variant. Histopathology showed no acute pneumonia or disease enhancement in any of the reinfection groups and, in addition, the expression of inflammatory cytokines and chemokines in the airways of reinfected animals was only mildly elevated. These findings are important for understanding the risk of reinfection with new variants of SARS-CoV-2. The emergence of SARS-CoV-2 variants and the widespread use of COVID-19 vaccines has resulted in individual differences in immune status against SARS-CoV-2. A decay in immunity over time and the emergence of variants that partially evade the immune response can also lead to reinfection. In this study, we demonstrated that, in hamsters, immunity acquired following primary infection with previous SARS-CoV-2 variants was effective in preventing the onset of pneumonia after reinfection with the Omicron variant. However, viral infection and multiplication in the upper respiratory tract were still observed after reinfection. We also showed that more diverse nonsynonymous mutations appeared in the upper respiratory tract of reinfected hamsters that had acquired immunity from primary infection. This hamster model reveals the within-host evolution of SARS-CoV-2 and its pathology after reinfection, and provides important information for countermeasures against diversifying SARS-CoV-2 variants. |
Author | Kuroda, Yudai Shirakura, Masayuki Suzuki, Tadaki Watanabe, Shinji Miura, Hideka Yamada, Souichi Nagata, Noriyo Yamamoto, Tsukasa Fujisaki, Seiichiro Iwata-Yoshikawa, Naoko Shiwa-Sudo, Nozomi Sakai, Yusuke Fukushi, Shuetsu Nagata, Shiho Miyazaki, Kaya Hasegawa, Hideki Maeda, Ken |
Author_xml | – sequence: 1 givenname: Nozomi surname: Shiwa-Sudo fullname: Shiwa-Sudo, Nozomi – sequence: 2 givenname: Yusuke surname: Sakai fullname: Sakai, Yusuke – sequence: 3 givenname: Naoko surname: Iwata-Yoshikawa fullname: Iwata-Yoshikawa, Naoko – sequence: 4 givenname: Shinji surname: Watanabe fullname: Watanabe, Shinji – sequence: 5 givenname: Souichi surname: Yamada fullname: Yamada, Souichi – sequence: 6 givenname: Yudai surname: Kuroda fullname: Kuroda, Yudai – sequence: 7 givenname: Tsukasa surname: Yamamoto fullname: Yamamoto, Tsukasa – sequence: 8 givenname: Masayuki surname: Shirakura fullname: Shirakura, Masayuki – sequence: 9 givenname: Seiichiro surname: Fujisaki fullname: Fujisaki, Seiichiro – sequence: 10 givenname: Kaya surname: Miyazaki fullname: Miyazaki, Kaya – sequence: 11 givenname: Hideka surname: Miura fullname: Miura, Hideka – sequence: 12 givenname: Shiho surname: Nagata fullname: Nagata, Shiho – sequence: 13 givenname: Shuetsu surname: Fukushi fullname: Fukushi, Shuetsu – sequence: 14 givenname: Ken surname: Maeda fullname: Maeda, Ken – sequence: 15 givenname: Hideki surname: Hasegawa fullname: Hasegawa, Hideki – sequence: 16 givenname: Tadaki surname: Suzuki fullname: Suzuki, Tadaki – sequence: 17 givenname: Noriyo surname: Nagata fullname: Nagata, Noriyo |
BookMark | eNpNUFFLwzAYDDLBOfcDfAv44kvrl7RJ08cxdA4GA6d7LUmasow1qUk33b93Uh98uuO4O467RSPnnUHonkBKCJAnCpSmINIMUgas5PwKjSkvaSIosNE_foOmMe4BgJacZEU-Rttl20ndY9_gYKxrjO6td_jL9ju8mb1tkrnfJhSvW6vDRT_JYKXrI7YOd8GcrD_GwxkPQVPjnWxjb0K8Q9eNPEQz_cMJ-nh5fp-_Jqv1YjmfrRJFIOdJoQootC5zzUBqUWsgtWhyTqhSRmhe57JQmglRU5MZriVRhjFtTJkxqRhkE_Q49Crrw7c9VV2wrQzn6veSCkSVQTVccrE-DNYu-M-jiX2198fgLusqWoAQBWN5nv0A6W1iyw |
ContentType | Paper |
Copyright | 2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022, Posted by Cold Spring Harbor Laboratory |
Copyright_xml | – notice: 2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022, Posted by Cold Spring Harbor Laboratory |
DBID | 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO GNUQQ HCIFZ LK8 M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS FX. |
DOI | 10.1101/2022.08.30.505966 |
DatabaseName | ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Coronavirus Research Database ProQuest Central ProQuest Central Student SciTech Premium Collection ProQuest Biological Science Collection Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China bioRxiv |
DatabaseTitle | Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Biological Science Collection ProQuest Central Essentials ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) |
DatabaseTitleList | Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: FX. name: bioRxiv url: https://www.biorxiv.org/ sourceTypes: Open Access Repository – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2692-8205 |
Edition | 1.2 |
ExternalDocumentID | 2022.08.30.505966v2 |
Genre | Working Paper/Pre-Print |
GroupedDBID | 8FE 8FH ABUWG AFKRA ALMA_UNASSIGNED_HOLDINGS AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO GNUQQ HCIFZ LK8 M7P NQS PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS PROAC RHI FX. |
ID | FETCH-LOGICAL-b1046-7b707cc94c50ac8dc01d8f4612bbe8c6d4a7bc588d2e3e6ca1be55cee935ab503 |
IEDL.DBID | BENPR |
ISSN | 2692-8205 |
IngestDate | Tue Jan 07 18:51:59 EST 2025 Fri Jul 25 09:20:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
License | This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b1046-7b707cc94c50ac8dc01d8f4612bbe8c6d4a7bc588d2e3e6ca1be55cee935ab503 |
Notes | SourceType-Working Papers-1 ObjectType-Working Paper/Pre-Print-1 content type line 50 Competing Interest Statement: The authors have declared no competing interest. |
ORCID | 0000-0001-9147-1438 0000-0002-3820-9542 |
OpenAccessLink | https://www.proquest.com/docview/2708875544?pq-origsite=%requestingapplication% |
PQID | 2708875544 |
PQPubID | 2050091 |
PageCount | 50 |
ParticipantIDs | biorxiv_primary_2022_08_30_505966 proquest_journals_2708875544 |
PublicationCentury | 2000 |
PublicationDate | 20220901 |
PublicationDateYYYYMMDD | 2022-09-01 |
PublicationDate_xml | – month: 09 year: 2022 text: 20220901 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cold Spring Harbor |
PublicationPlace_xml | – name: Cold Spring Harbor |
PublicationTitle | bioRxiv |
PublicationYear | 2022 |
Publisher | Cold Spring Harbor Laboratory Press Cold Spring Harbor Laboratory |
Publisher_xml | – name: Cold Spring Harbor Laboratory Press – name: Cold Spring Harbor Laboratory |
References | Pannone, Caponio, De Stefano, Ramunno, Meccariello, Agostinone, Pedicillo, Troiano, Zhurakivska, Cassano, Bizzoca, Papagerakis, Buonaguro, Advani, Muzio (2022.08.30.505966v2.21) 2021; 16 Bourgonje, Abdulle, Timens, Hillebrands, Navis, Gordijn, Bolling, Dijkstra, Voors, Osterhaus, van der Voort, Mulder, van Goor (2022.08.30.505966v2.46) 2020; 251 Hachmann, Miller, Collier, Ventura, Yu, Rowe, Bondzie, Powers, Surve, Hall, Barouch (2022.08.30.505966v2.28) 2022; 387 Iwata-Yoshikawa, Shiwa, Sekizuka, Sano, Ainai, Hemmi, Kataoka, Kuroda, Hasegawa, Suzuki, Nagata (2022.08.30.505966v2.52) 2022; 8 (2022.08.30.505966v2.2) 2021 Zivcec, Safronetz, Haddock, Feldmann, Ebihara (2022.08.30.505966v2.56) 2011; 368 Wang, Sewatanon, Memoli, Wrammert, Bournazos, Bhaumik, Pinsky, Chokephaibulkit, Onlamoon, Pattanapanyasat, Taubenberger, Ahmed, Ravetch (2022.08.30.505966v2.43) 2017; 355 Polak, Van Gool, Cohen, von der Thüsen, van Paassen (2022.08.30.505966v2.20) 2020; 33 2022.08.30.505966v2.1 Halfmann, Kuroda, Armbrust, Accola, Valdez, Kowalski-Dobson, Rehrauer, Gordon, Kawaoka (2022.08.30.505966v2.19) 2022; 38 Cromer, Juno, Khoury, Reynaldi, Wheatley, Kent, Davenport (2022.08.30.505966v2.11) 2021; 21 Mykytyn, Rissmann, Kok, Rosu, Schipper, Breugem, van den Doel, Chandler, Bestebroer, de Wit, van Royen, Molenkamp, Oude Munnink, de Vries, GeurtsvanKessel, Smith, Koopmans, Rockx, Lamers, Fouchier, Haagmans (2022.08.30.505966v2.30) 2022 Smid, Berec, Pribylova, Majek, Pavlik, Jarkovsky, Weiner, Barusova, Trnka (2022.08.30.505966v2.50) 2022 Liu, Soh, Kishikawa, Hirose, Nakayama, Li, Sasai, Suzuki, Tada, Arakawa, Matsuoka, Akamatsu, Matsuda, Ono, Torii, Kishida, Jin, Nakai, Arase, Nakagawa, Matsumoto, Nakazaki, Shindo, Kohyama, Tomii, Ohmura, Ohshima, Okamoto, Yamamoto, Nakagami, Matsuura, Nakagawa, Kato, Okada, Standley, Shioda, Arase (2022.08.30.505966v2.42) 2021; 184 Fall, Eldesouki, Sachithanandham, Morris, Norton, Gaston, Forman, Abdullah, Gallagher, Li, Swanson, Pekosz, Klein, Mostafa (2022.08.30.505966v2.10) 2022; 79 Itokawa, Sekizuka, Hashino, Tanaka, Kuroda (2022.08.30.505966v2.58) 2020; 15 Pulliam, Schalkwyk, Govender, Gottberg, Cohen, Groome, Dushoff, Mlisana, Moultrie (2022.08.30.505966v2.6) 2022; 376 Rosenke, Meade-White, Letko, Clancy, Hansen, Liu, Okumura, Tang-Huau, Li, Saturday, Feldmann, Scott, Wang, Munster, Jarvis, Feldmann (2022.08.30.505966v2.13) 2020; 9 Wilhelm, Widera, Grikscheit, Toptan, Schenk, Pallas, Metzler, Kohmer, Hoehl, Marschalek, Herrmann, Helfritz, Wolf, Goetsch, Ciesek (2022.08.30.505966v2.24) 2022; 82 Quick (2022.08.30.505966v2.57) 2020 Sun, Wang, Tan, Dan, Lu, Zhang, Xu, Tan, Xiang, Zhou, He, Wan, Zhang, Chen, Tan, Deng (2022.08.30.505966v2.34) 2021; 9 Altarawneh, Chemaitelly, Hasan, Ayoub, Qassim, AlMukdad, Coyle, Yassine, Al-Khatib, Benslimane, Al-Kanaani, Al-Kuwari, Jeremijenko, Kaleeckal, Latif, Shaik, Abdul-Rahim, Nasrallah, Al-Kuwari, Butt, Al-Romaihi, Al-Thani, Al-Khal, Bertollini, Tang, Abu-Raddad (2022.08.30.505966v2.48) 2022; 386 Boyton, Altmann (2022.08.30.505966v2.32) 2021; 21 Zhou, Yang, Wang, Hu, Zhang, Zhang, Si, Zhu, Li, Huang (2022.08.30.505966v2.35) 2020; 579 Weiss, Scott (2022.08.30.505966v2.45) 1981; 4 Siggins, Thwaites, Openshaw (2022.08.30.505966v2.33) 2021; 29 Viana, Moyo, Amoako, Tegally, Scheepers, Althaus, Anyaneji, Bester, Boni, Chand, Choga, Colquhoun, Davids, Deforche, Doolabh, du Plessis, Engelbrecht, Everatt, Giandhari, Giovanetti, Hardie, Hill, Hsiao, Iranzadeh, Ismail, Joseph, Joseph, Koopile, Kosakovsky Pond, Kraemer, Kuate-Lere, Laguda-Akingba, Lesetedi-Mafoko, Lessells, Lockman, Lucaci, Maharaj, Mahlangu, Maponga, Mahlakwane, Makatini, Marais, Maruapula, Masupu, Matshaba, Mayaphi, Mbhele, Mbulawa, Mendes, Mlisana (2022.08.30.505966v2.3) 2022; 603 Nunez, Lien, Selvaraj, Stauft, Liu, Starost, Wang (2022.08.30.505966v2.16) 2021 Shrestha, Foster, Rawlinson, Tedla, Bull (2022.08.30.505966v2.27) 2022 Madhi, Kwatra, Myers, Jassat, Dhar, Mukendi, Nana, Blumberg, Welch, Ngorima-Mabhena, Mutevedzi (2022.08.30.505966v2.9) 2022; 386 Dhakal, Ruiz-Bedoya, Zhou, Creisher, Villano, Littlefield, Ruelas Castillo, Marinho, Jedlicka, Ordonez, Bahr, Majewska, Betenbaugh, Flavahan, Mueller, Looney, Quijada, Mota, Beck, Brockhurst, Braxton, Castell, Stover, D’Alessio, Metcalf Pate, Karakousis, Mankowski, Pekosz, Jain, Klein, Johns Hopkins (2022.08.30.505966v2.31) 2021; 12 Rothberg, Kim, Shrestha, Kojima, Tereshchenko (2022.08.30.505966v2.49) 2022 Cao, Wang, Jian, Xiao, Song, Yisimayi, Huang, Li, Wang, An, Wang, Wang, Niu, Yang, Liang, Sun, Li, Yu, Cui, Liu, Yang, Du, Zhang, Hao, Shao, Jin, Wang, Xiao, Wang, Xie (2022.08.30.505966v2.23) 2022; 602 Chan, Zhang, Yuan, Poon, Chan, Lee, Chan, Fan, Tsoi, Wen, Liang, Cao, Chen, Tang, Luo, Cai, Kok, Chu, Chan, Sridhar, Chen, Chen, To, Yuen (2022.08.30.505966v2.14) 2020 Wu, Zhao, Yu, Chen, Wang, Song, Hu, Tao, Tian, Pei, Yuan, Zhang, Dai, Liu, Wang, Zheng, Xu, Holmes, Zhang (2022.08.30.505966v2.39) 2020; 579 Abdelnabi, Boudewijns, Foo, Seldeslachts, Sanchez-Felipe, Zhang, Delang, Maes, Kaptein, Weynand, Vande Velde, Neyts, Dallmeier (2022.08.30.505966v2.17) 2021; 68 Matsuyama, Nao, Shirato, Kawase, Saito, Takayama, Nagata, Sekizuka, Katoh, Kato, Sakata, Tahara, Kutsuna, Ohmagari, Kuroda, Suzuki, Kageyama, Takeda (2022.08.30.505966v2.53) 2020; 117 Karim, Karim (2022.08.30.505966v2.4) 2021; 398 Rodrigues, de Castro, de Albuquerque, Mattaraia, Santoro (2022.08.30.505966v2.55) 2017; 12 Oliviero, de Castro, Coperchini, Chiovato, Rotondi (2022.08.30.505966v2.51) 2021; 27 Halfmann, Iida, Iwatsuki-Horimoto, Maemura, Kiso, Scheaffer, Darling, Joshi, Loeber, Singh, Foster, Ying, Case, Chong, Whitener, Moliva, Floyd, Ujie, Nakajima, Ito, Wright, Uraki, Warang, Gagne, Li, Sakai-Tagawa, Liu, Larson, Osorio, Hernandez-Ortiz, Henry, Ciouderis, Florek, Patel, Odle, Wong, Bateman, Wang, Edara, Chong, Franks, Jeevan, Fabrizio, DeBeauchamp, Kercher, Seiler, Gonzalez-Reiche, Sordillo, Chang, van Bakel (2022.08.30.505966v2.7) 2022 Tran, Taira, Ogawa, Misu, Miyazawa, Kitao (2022.08.30.505966v2.36) 2022; 12 Imai, Iwatsuki-Horimoto, Hatta, Loeber, Halfmann, Nakajima, Watanabe, Ujie, Takahashi, Ito, Yamada, Fan, Chiba, Kuroda, Guan, Takada, Armbrust, Balogh, Furusawa, Okuda, Ueki, Yasuhara, Sakai-Tagawa, Lopes, Kiso, Yamayoshi, Kinoshita, Ohmagari, Hattori, Takeda, Mitsuya, Krammer, Suzuki, Kawaoka (2022.08.30.505966v2.15) 2020; 117 Cameroni, Bowen, Rosen, Saliba, Zepeda, Culap, Pinto, VanBlargan, De Marco, di Iulio, Zatta, Kaiser, Noack, Farhat, Czudnochowski, Havenar-Daughton, Sprouse, Dillen, Powell, Chen, Maher, Yin, Sun, Soriaga, Bassi, Silacci-Fregni, Gustafsson, Franko, Logue, Iqbal, Mazzitelli, Geffner, Grifantini, Chu, Gori, Riva, Giannini, Ceschi, Ferrari, Cippa, Franzetti-Pellanda, Garzoni, Halfmann, Kawaoka, Hebner, Purcell, Piccoli, Pizzuto, Walls, Diamond (2022.08.30.505966v2.22) 2022; 602 Li, Hou, Ma, Wang, Wang, Yu, Chang, Wang, Jin, Wang, Wang, Zhao, Zhao, Xu, Ma, Gao, He (2022.08.30.505966v2.40) 2022; 19 Wolter, Jassat, Walaza, Welch, Moultrie, Groome, Amoako, Everatt, Bhiman, Scheepers, Tebeila, Chiwandire, du Plessis, Govender, Ismail, Glass, Mlisana, Stevens, Treurnicht, Makatini, Hsiao, Parboosing, Wadula, Hussey, Davies, Boulle, von Gottberg, Cohen (2022.08.30.505966v2.5) 2022; 399 Wong, Perlman (2022.08.30.505966v2.12) 2022; 22 Itokawa, Sekizuka, Hashino, Tanaka, Eto, Someno, Kuroda (2022.08.30.505966v2.59) 2021 Andeweg, de Gier, Eggink, van den Ende, van Maarseveen, Ali, Vlaemynck, Schepers, Hahne, Reusken, de Melker, van den Hof, Knol (2022.08.30.505966v2.26) 2022; 13 Pastorio, Zech, Noettger, Jung, Jacob, Sanderson, Sparrer, Kirchhoff (2022.08.30.505966v2.25) 2022 Yuen, Lam, Wong, Mak, Wang, Chu, Cai, Jin, To, Chan, Yuen, Kok (2022.08.30.505966v2.38) 2020; 9 Yamada, Fukushi, Kinoshita, Ohnishi, Suzuki, Fujimoto, Saijo, Maeda (2022.08.30.505966v2.54) 2021; 8 Hansen, Meade-White, Clancy, Rosenke, Okumura, Hawman, Feldmann, Kaza, Jarvis, Rosenke, Feldmann (2022.08.30.505966v2.18) 2022; 38 Kindler, Gil-Cruz, Spanier, Li, Wilhelm, Rabouw, Zust, Hwang, V’Kovski, Stalder, Marti, Habjan, Cervantes-Barragan, Elliot, Karl, Gaughan, van Kuppeveld, Silverman, Keller, Ludewig, Bergmann, Ziebuhr, Weiss, Kalinke, Thiel (2022.08.30.505966v2.37) 2017; 13 Vennema, de Groot, Harbour, Dalderup, Gruffydd-Jones, Horzinek, Spaan (2022.08.30.505966v2.44) 1990; 64 Munoz-Fontela, Dowling, Funnell, Gsell, Riveros-Balta, Albrecht, Andersen, Baric, Carroll, Cavaleri, Qin, Crozier, Dallmeier, de Waal, de Wit, Delang, Dohm, Duprex, Falzarano, Finch, Frieman, Graham, Gralinski, Guilfoyle, Haagmans, Hamilton, Hartman, Herfst, Kaptein, Klimstra, Knezevic, Krause, Kuhn, Le Grand, Lewis, Liu, Maisonnasse, McElroy, Munster, Oreshkova, Rasmussen, Rocha-Pereira, Rockx, Rodriguez, Rogers, Salguero, Schotsaert, Stittelaar, Thibaut, Tseng (2022.08.30.505966v2.29) 2020; 586 Halstead, Katzelnick (2022.08.30.505966v2.47) 2020; 222 Itokawa, Sasaki (2022.08.30.505966v2.60) 2021 Yang, Lin, Tsai, Chien, Wang, Yang, Chang (2022.08.30.505966v2.41) 2021; 84 Iuliano, Brunkard, Boehmer, Peterson, Adjei, Binder, Cobb, Graff, Hidalgo, Panaggio, Rainey, Rao, Soetebier, Wacaster, Ai, Gupta, Molinari, Ritchey (2022.08.30.505966v2.8) 2022; 71 |
References_xml | – volume: 9 start-page: 1418 year: 2020 end-page: 1428 ident: 2022.08.30.505966v2.38 article-title: SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists publication-title: Emerg Microbes Infect – ident: 2022.08.30.505966v2.1 publication-title: WHO coronavirus disease (COVID-19) dashboard – volume: 603 start-page: 679 year: 2022 end-page: 686 ident: 2022.08.30.505966v2.3 article-title: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa publication-title: Nature – volume: 9 start-page: 2673 year: 2020 end-page: 2684 ident: 2022.08.30.505966v2.13 article-title: Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection publication-title: Emerging Microbes & Infections – volume: 8 start-page: eabh3827 year: 2022 ident: 2022.08.30.505966v2.52 article-title: A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection publication-title: Sci Adv – volume: 117 start-page: 7001 year: 2020 end-page: 7003 ident: 2022.08.30.505966v2.53 article-title: Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells publication-title: Proc Natl Acad Sci U S A – year: 2021 ident: 2022.08.30.505966v2.59 article-title: nCoV-2019 sequencing protocol for illumina., on protocols.io – year: 2022 ident: 2022.08.30.505966v2.49 article-title: Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study publication-title: Clin Infect Dis. – volume: 13 start-page: 4738 year: 2022 ident: 2022.08.30.505966v2.26 article-title: Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections publication-title: Nat Commun – volume: 71 start-page: 146 year: 2022 end-page: 152 ident: 2022.08.30.505966v2.8 article-title: Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022 publication-title: MMWR Morb Mortal Wkly Rep – volume: 12 start-page: e0097421 year: 2021 ident: 2022.08.30.505966v2.31 article-title: Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model publication-title: mBio – year: 2022 ident: 2022.08.30.505966v2.25 article-title: Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2 publication-title: Cell Host Microbe – volume: 386 start-page: 1314 year: 2022 end-page: 1326 ident: 2022.08.30.505966v2.9 article-title: Population Immunity and Covid-19 Severity with Omicron Variant in South Africa publication-title: New England Journal of Medicine – volume: 79 start-page: 104008 year: 2022 ident: 2022.08.30.505966v2.10 article-title: The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads publication-title: eBioMedicine – volume: 22 start-page: 47 year: 2022 end-page: 56 ident: 2022.08.30.505966v2.12 article-title: Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy? publication-title: Nature Reviews Immunology – volume: 117 start-page: 16587 year: 2020 end-page: 16595 ident: 2022.08.30.505966v2.15 article-title: Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development publication-title: Proc Natl Acad Sci U S A – year: 2020 ident: 2022.08.30.505966v2.57 article-title: nCoV-2019 sequencing protocol v3 (LoCost), on Version created by Josh Quick – volume: 27 start-page: 214 year: 2021 end-page: 221 ident: 2022.08.30.505966v2.51 article-title: COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator? publication-title: Neuroscientist – start-page: eabq4450 year: 2022 ident: 2022.08.30.505966v2.30 article-title: Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct publication-title: Sci Immunol – volume: 386 start-page: 1288 year: 2022 end-page: 1290 ident: 2022.08.30.505966v2.48 article-title: Protection against the Omicron Variant from Previous SARS-CoV-2 Infection publication-title: N Engl J Med – volume: 64 start-page: 1407 year: 1990 end-page: 1409 ident: 2022.08.30.505966v2.44 article-title: Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization publication-title: J Virol – volume: 33 start-page: 2128 year: 2020 end-page: 2138 ident: 2022.08.30.505966v2.20 article-title: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression publication-title: Modern Pathology – start-page: e2381 year: 2022 ident: 2022.08.30.505966v2.27 article-title: Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission publication-title: Rev Med Virol – volume: 9 start-page: e00261 year: 2021 end-page: 00221 ident: 2022.08.30.505966v2.34 article-title: SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants publication-title: Microbiology Spectrum – volume: 184 start-page: 3452 year: 2021 end-page: 3466 e3418 ident: 2022.08.30.505966v2.42 article-title: An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies publication-title: Cell – volume: 21 start-page: 762 year: 2021 end-page: 768 ident: 2022.08.30.505966v2.32 article-title: The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions? publication-title: Nature Reviews Immunology – volume: 4 start-page: 175 year: 1981 end-page: 189 ident: 2022.08.30.505966v2.45 article-title: Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever publication-title: Comp Immunol Microbiol Infect Dis – volume: 19 start-page: 67 year: 2022 end-page: 78 ident: 2022.08.30.505966v2.40 article-title: SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy publication-title: Cell Mol Immunol – volume: 15 start-page: e0239403 year: 2020 ident: 2022.08.30.505966v2.58 article-title: Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR publication-title: PLoS One – year: 2022 ident: 2022.08.30.505966v2.50 article-title: Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2 publication-title: J Infect Dis. – volume: 13 start-page: e1006195 year: 2017 ident: 2022.08.30.505966v2.37 article-title: Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication publication-title: PLoS Pathog – volume: 82 start-page: 104158 year: 2022 ident: 2022.08.30.505966v2.24 article-title: Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies publication-title: EBioMedicine – year: 2021 ident: 2022.08.30.505966v2.2 article-title: Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern, on World Health Organization – start-page: e0050721 year: 2021 ident: 2022.08.30.505966v2.16 article-title: SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection publication-title: mSphere – volume: 399 start-page: 437 year: 2022 end-page: 446 ident: 2022.08.30.505966v2.5 article-title: Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study publication-title: The Lancet – volume: 12 start-page: e0177967 year: 2017 ident: 2022.08.30.505966v2.55 article-title: The gingival vein as a minimally traumatic site for multiple blood sampling in guinea pigs and hamsters publication-title: PLoS One – volume: 602 start-page: 657 year: 2022 end-page: 663 ident: 2022.08.30.505966v2.23 article-title: Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies publication-title: Nature – volume: 38 year: 2022 ident: 2022.08.30.505966v2.18 article-title: SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract publication-title: Cell Reports – volume: 355 start-page: 395 year: 2017 end-page: 398 ident: 2022.08.30.505966v2.43 article-title: IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity publication-title: Science – volume: 376 start-page: eabn4947 year: 2022 ident: 2022.08.30.505966v2.6 article-title: Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa publication-title: Science – volume: 602 start-page: 664 year: 2022 end-page: 670 ident: 2022.08.30.505966v2.22 article-title: Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift publication-title: Nature – volume: 222 start-page: 1946 year: 2020 end-page: 1950 ident: 2022.08.30.505966v2.47 article-title: COVID-19 Vaccines: Should We Fear ADE? publication-title: J Infect Dis – volume: 398 start-page: 2126 year: 2021 end-page: 2128 ident: 2022.08.30.505966v2.4 article-title: Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic publication-title: The Lancet – volume: 586 start-page: 509 year: 2020 end-page: 515 ident: 2022.08.30.505966v2.29 article-title: Animal models for COVID-19 publication-title: Nature – volume: 8 year: 2021 ident: 2022.08.30.505966v2.54 article-title: Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells publication-title: BMJ Open Respir Res – volume: 68 start-page: 103403 year: 2021 ident: 2022.08.30.505966v2.17 article-title: Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters publication-title: EBioMedicine – volume: 29 start-page: 648 year: 2021 end-page: 662 ident: 2022.08.30.505966v2.33 article-title: Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses publication-title: Trends in Microbiology – year: 2022 ident: 2022.08.30.505966v2.7 article-title: SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters publication-title: Nature – volume: 387 start-page: 86 year: 2022 end-page: 88 ident: 2022.08.30.505966v2.28 article-title: Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 publication-title: N Engl J Med – volume: 21 start-page: 395 year: 2021 end-page: 404 ident: 2022.08.30.505966v2.11 article-title: Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection publication-title: Nature Reviews Immunology – year: 2020 ident: 2022.08.30.505966v2.14 article-title: Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility publication-title: Clin Infect Dis. – volume: 84 start-page: 478 year: 2021 end-page: 484 ident: 2022.08.30.505966v2.41 article-title: Pandemic analysis of infection and death correlated with genomic open reading frame 10 mutation in severe acute respiratory syndrome coronavirus 2 victims publication-title: J Chin Med Assoc – volume: 16 start-page: 34 year: 2021 ident: 2022.08.30.505966v2.21 article-title: Lung histopathological findings in COVID-19 disease – a systematic review publication-title: Infectious Agents and Cancer – volume: 579 start-page: 270 year: 2020 end-page: 273 ident: 2022.08.30.505966v2.35 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: nature – volume: 368 start-page: 24 year: 2011 end-page: 35 ident: 2022.08.30.505966v2.56 article-title: Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus) publication-title: J Immunol Methods – volume: 251 start-page: 228 year: 2020 end-page: 248 ident: 2022.08.30.505966v2.46 article-title: Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) publication-title: J Pathol – volume: 579 start-page: 265 year: 2020 end-page: 269 ident: 2022.08.30.505966v2.39 article-title: A new coronavirus associated with human respiratory disease in China publication-title: Nature – volume: 12 start-page: 3860 year: 2022 ident: 2022.08.30.505966v2.36 article-title: Inhibition of the hexamerization of SARS-CoV-2 endoribonuclease and modeling of RNA structures bound to the hexamer publication-title: Sci Rep – year: 2021 ident: 2022.08.30.505966v2.60 article-title: Alt_nCov2019_primers_v0.11, on github.com – volume: 38 year: 2022 ident: 2022.08.30.505966v2.19 article-title: Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model publication-title: Cell Reports |
SSID | ssj0002961374 |
Score | 1.6666367 |
SecondaryResourceType | preprint |
Snippet | The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further... |
SourceID | biorxiv proquest |
SourceType | Open Access Repository Aggregation Database |
SubjectTerms | Amino acids Chemokines Cytokines Infections Inflammation Microbiology Mutation Replication Respiratory tract diseases RNA viruses Severe acute respiratory syndrome coronavirus 2 Viral infections |
SummonAdditionalLinks | – databaseName: bioRxiv dbid: FX. link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LSwMxEA7aInjziY8qEbympJtkkz1KsVTBB9aW3pa8Fgt2t2xrsf_eTHcrgh68LmQXviQz8818O4PQteSGiSwTJDGeEh5ZS4wVjCgnbaSdzZyDPOTDY9wf8vuxGP8Y9QWySjMpys_Jcl3HB8F2sL7V5aYd4OoR9NxktC1gcky8jZrhSHG4k71x-zu9EiXBT0le1zH_XBki3vpLv-zw2rn09lDzWc98uY-2fH6AdqrpkKtDNLpb_8GIiwyXfiOayjFkTvHg5mVAusWIRPhpCpq6HC8D6wVRC57keAbi3cDp31e4WugdftNTaIowP0LD3u1rt0_qMQjEQAGWSCOptDbhVlBtlbO041TGQ2hijFc2dlzLgK9SLvLMx1Z3jBciOL-ECW0EZceokRe5P0HYhm0JDMzpmLtArKxWhiuWicRkLA5e6hRd1ZCks6rZRQqwpVSljKYVbKeotQErrc_7PI0kWKsQmvCzf7ziHO3Cs0qq1UKNRfnhL4JvX5jL9S5-AWqBn54 priority: 102 providerName: Cold Spring Harbor Laboratory Press |
Title | Impact of reinfection with SARS-CoV-2 Omicron variants in previously infected hamsters |
URI | https://www.proquest.com/docview/2708875544 https://www.biorxiv.org/content/10.1101/2022.08.30.505966 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEF5si-DNJ9YXK3jduu4j2ZxES4sKamlVegv7ChZsUlst9t-706R6EDyHzWEmM9_OzJf5EDqLheEyyyRJjKdEMGuJsZIT5WLLtLOZc9CHvH-Ibp7F3VAOq4bbrKJVrnLiMlG7wkKP_JzFEA8B_MTl5J2AahRMVysJjRpqhBSsVB01rjsPvf5Pl4UlAa6Wq5hZlITQZ1RWo83wKULhz2CBJ6ctCTI0cAk2o2L6NZr_Sc1LvOluokZPT_x0C635fButl4KRix30crv8qREXGZ76FY8qx9BMxYOr_oC0ixfC8OMYaHY5nodCGHgueJTjCfB5Q5n_tsDlQe_wqx7DnoTZLnrudp7aN6RSRiAGZrIkNjGNrU2ElVRb5Sy9cCoT4bZijFc2ckLHweRKOea5j6y-MF7KgIcJl9pIyvdQPS9yv4-wDZ4KRZnTkXCh1rJaGaF4JhOT8SgAVxOdViZJJ-X-ixTMllKVcpqWZmuio5Wx0ioEZumvww7-f3yINuCNJXHrCNU_pp_-OCD9hzmp3HmCat1h6xtrPagB |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LTxsxEB5BooreCrQqLQ8jlaNb48eu91BVLQ8lBVLES9y2fq0aqeymCY_mT_U34snu0gMSN86WLWs8ns8z83kG4EMqrVBFoWhmA6OSO0etU4JqnzpuvCu8xzjk0SDpncvvl-pyDv61f2GQVtnaxJmh9pXDGPknnuJ9iOAnv4z-UOwahdnVtoVGrRYHYXoXXbbJ5_5uPN8tzvf3znZ6tOkqQC3mM2lqU5Y6l0mnmHHaO7btdSEj0lsbtEu8NGncrtaeBxESZ7ZtUCpiSSaUsYqJuO48dKVIGO9A99ve4PjkIarDswiPs9LPPMmiqeFMNanUqPoYaOBYMFSwjwrb3uCj2w6r8d_h7SMomOHb_ivoHptRGC_CXCiX4EXdoHK6DBf92SdKUhVkHFreVkkweEtOv56c0p3qgnLy4wppfSW5jY438mrIsCQj5A9XN5PfU1JPDJ78MldYl2HyGs6fRWZvoFNWZXgLxEXNiE6gN4n00bdzRlupRaEyW4gkAuUKbDYiyUd1vY0cxZYznQuW12JbgdVWWHlz5Sb5fwV59_TwBiz0zo4O88P-4OA9vMTVa9LYKnSuxzdhLb4yru16c7QEfj63Nt0DCjblXQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LTxRBEK4gBOMNFSKK2iZw7E1vP2Z6DhwMuGFFkPDK3sZ-TdhEZja7gO7f8hdatTPrRQ9eOE-m011d3V89vq4C2M21V6aqDC98ElzLELgPRnEb8yBdDFWMFIc8Oc2OrvTnkRmtwK_lWxiiVfpxM_05fljk8Ymwjbdve7hFn3x1STU3legZ6hyT9ShM3ZvEqiNWHqf5D3TbZvvDQ9zjPSkHny4PjnjXWYB7ymny3OciD6HQwQgXbAyiH22lEe29TzZkUbscp2xtlEmlLLi-T8YgnhTKOG-EwnGfwBrqsqZ2EYNR709cRxYIkLnuEqj_nDKa2t0S_wKABaoNNmDtzE3S9DmspPoFrLdtKecv4Xq4eDrJmopN05KtVTMK2bKLj-cX_KC55pJ9vSUyX80e0N0mNg0b12xCrOHmfvZ9ztofU2Q37paqMcw24epRpLQFq3VTp1fAAuoDun7RZTqiRxec9dqqyhS-UhnC4zZ86ERSTtoqGyWJrRS2VKJsxbYNO0thld1Bm5Uyp2sSbSL9-j-GeA9Pzw4H5Zfh6fEbeEafW7rYDqzeTe_TW7Qv7vy7xYYy-PbYGvQbiVjg-w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+reinfection+with+SARS-CoV-2+Omicron+variants+in+previously+infected+hamsters&rft.jtitle=bioRxiv&rft.au=Shiwa-Sudo%2C+Nozomi&rft.au=Sakai%2C+Yusuke&rft.au=Iwata-Yoshikawa%2C+Naoko&rft.au=Watanabe%2C+Shinji&rft.date=2022-09-01&rft.pub=Cold+Spring+Harbor+Laboratory+Press&rft.issn=2692-8205&rft.eissn=2692-8205&rft_id=info:doi/10.1101%2F2022.08.30.505966 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2692-8205&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2692-8205&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2692-8205&client=summon |